Fulton Bank N.A. Sells 3,511 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Fulton Bank N.A. decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 25.7% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,172 shares of the healthcare conglomerate’s stock after selling 3,511 shares during the quarter. Fulton Bank N.A.’s holdings in UnitedHealth Group were worth $5,947,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of UNH. Delta Financial Group Inc. lifted its stake in UnitedHealth Group by 1.0% in the third quarter. Delta Financial Group Inc. now owns 1,650 shares of the healthcare conglomerate’s stock valued at $965,000 after acquiring an additional 17 shares during the last quarter. Signature Resources Capital Management LLC boosted its stake in shares of UnitedHealth Group by 40.0% in the 2nd quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock valued at $32,000 after purchasing an additional 18 shares in the last quarter. Saxony Capital Management LLC boosted its stake in shares of UnitedHealth Group by 3.5% in the 2nd quarter. Saxony Capital Management LLC now owns 530 shares of the healthcare conglomerate’s stock valued at $270,000 after purchasing an additional 18 shares in the last quarter. GoalVest Advisory LLC lifted its position in shares of UnitedHealth Group by 0.6% in the 2nd quarter. GoalVest Advisory LLC now owns 3,124 shares of the healthcare conglomerate’s stock worth $1,591,000 after purchasing an additional 18 shares during the period. Finally, Fiduciary Group LLC increased its stake in shares of UnitedHealth Group by 0.5% in the 2nd quarter. Fiduciary Group LLC now owns 3,695 shares of the healthcare conglomerate’s stock valued at $1,882,000 after acquiring an additional 18 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have issued reports on UNH shares. Truist Financial lifted their price objective on shares of UnitedHealth Group from $600.00 to $640.00 and gave the stock a “buy” rating in a report on Wednesday, July 17th. Jefferies Financial Group upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and upped their price target for the company from $481.00 to $647.00 in a research report on Wednesday, July 17th. StockNews.com cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Wednesday, September 25th. Morgan Stanley increased their price objective on UnitedHealth Group from $595.00 to $615.00 and gave the company an “overweight” rating in a research note on Wednesday, July 17th. Finally, Argus raised their price target on UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a research note on Wednesday, July 17th. Two investment analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $614.17.

UnitedHealth Group Stock Down 1.3 %

UnitedHealth Group stock traded down $7.64 during mid-day trading on Monday, hitting $583.56. The company had a trading volume of 2,533,817 shares, compared to its average volume of 3,958,113. The stock has a market cap of $537.10 billion, a price-to-earnings ratio of 35.79, a PEG ratio of 1.65 and a beta of 0.58. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $607.94. The business has a fifty day moving average of $582.24 and a 200 day moving average of $527.84. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, beating the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The business had revenue of $98.86 billion during the quarter, compared to the consensus estimate of $98.73 billion. During the same period in the prior year, the company earned $6.14 earnings per share. The company’s revenue was up 6.4% compared to the same quarter last year. On average, sell-side analysts expect that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were given a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.44%. The ex-dividend date of this dividend was Monday, September 16th. UnitedHealth Group’s dividend payout ratio is currently 51.34%.

Insider Buying and Selling

In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the sale, the chief accounting officer now owns 29,501 shares in the company, valued at $16,812,029.88. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the sale, the executive vice president now directly owns 7,785 shares in the company, valued at $4,507,748.55. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the sale, the chief accounting officer now owns 29,501 shares in the company, valued at $16,812,029.88. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.33% of the stock is currently owned by company insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.